Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The BD Liverty™ TIPS Stent Graft Study

NCT: NCT05711316 · ACTIVE_NOT_RECRUITING

NCT IDNCT05711316
StatusACTIVE_NOT_RECRUITING
Start Date2023-08-08
Completion2027-01-11
SponsorC. R. Bard (INDUSTRY)
First posted
Last updated

Brief Summary

The objective of the study is to assess the safety and effectiveness of the BD Liverty™ TIPS Stent Graft for the treatment of the complications of portal hypertension from cirrhosis. This includes recurrent or refractory ascites, hepatic hydrothorax, and/or variceal bleeding (esophageal and/or gastric).

Frequently Asked Questions

What is The BD Liverty™ TIPS Stent Graft Study?

The BD Liverty™ TIPS Stent Graft Study is a clinical trial registered under NCT05711316. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05711316?

The current status of NCT05711316 (The BD Liverty™ TIPS Stent Graft Study) is: ACTIVE_NOT_RECRUITING.

When did The BD Liverty™ TIPS Stent Graft Study start?

The BD Liverty™ TIPS Stent Graft Study started on 2023-08-08.

Related Devices

PMA P170042System, endovascular graft, arteriovenous (AV) dialysis access circuit stenosis treatmentC.R. Bard, Inc. K151985PowerPICC® EtOH Catheter and PowerPICC SOLO®2 EtOH CatheterC.R. Bard, Inc. K152136Recovery Cone Removal SystemC.R. Bard, Inc. K152613True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. K153190Zenysis Short-Term Dialysis CatheterC.R. Bard, Inc.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑